Condition: Prostate Cancer · Sponsor: Changhai Hospital
Hypofractionated radiation therapy is a new type of radiotherapy which has been shown to play a larger role in the treatment of prostate cancer. The aims of the trial were to evaluate the safety and feasibility of adjuvant hypofractionated radiotherapy following radical prostatectomy for prostate cancer.
This description comes directly from the study's public registry record.
Huojun Zhang, PhD · 021-31162222 · huojunzh@163.com
Xianzhi Zhao, PhD · 021-31162222 · zhxzh0007@163.com
Always discuss trial participation with your own doctor first.
| The First Affiliated Hospital of Naval Medical University | Shanghai, Shanghai Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06335693